Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients

K. Fujita, Y. Nagasaka, M. Fujita, N. Nakano, A. Miyatake (Hikone, Sakai, Kyoto, Osaka, Japan)

Source: Annual Congress 2002 - Steroid and other anti-inflammatory agents
Session: Steroid and other anti-inflammatory agents
Session type: Thematic Poster Session
Number: 1915
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Fujita, Y. Nagasaka, M. Fujita, N. Nakano, A. Miyatake (Hikone, Sakai, Kyoto, Osaka, Japan). Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients. Eur Respir J 2002; 20: Suppl. 38, 1915

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010

Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007


Evaluation of adherence of patients with asthma to treatment by single combination inhaler
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Adherence of stable COPD patients to inhaled pharmacotherapy
Source: Annual Congress 2011 - COPD management
Year: 2011


The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001

Adherence to inhaled controller therapy and local adverse events in children with asthma
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009


Determinants of adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Barriers to adherence to inhaled corticosteroids in a high adherent population of children with asthma
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012



Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Control of persistent asthma patients on inhaled corticosteroids in a real-life setting
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010


Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab
Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018
Year: 2018



Switching asthma patients using high-dose inhaled steroids to budesonide/formoterol maintenance and reliever therapy
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Adherence to inhaled steroids treatment using smart nebulisers in severe asthmatics
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Characteristics of COPD patients treated with inhaled corticosteroid in primary care
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

Suboptimal persistence with inhaled corticosteroid (ICS) mono-therapy among children with persistent asthma in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 709s
Year: 2006